
Allergan Inc. (NYSE: AGN) was downgraded to Neutral from Buy at Goldman Sachs.
Cardinal Health Inc. (NYSE: CAH) upgraded to Outperform from Market Perform at William Blair.
Chevron Corp. (NYSE: CVX) was started as Outperform at Wells Fargo (late Thursday call).
Exxon Mobil Corp. (NYSE: XOM) was started as Market Perform at Wells Fargo (late Thursday call).
Read also: Deutsche Bank Picks Large Cap Dividend Growers
Facebook Inc. (NASDAQ: FB) upgraded to Buy from Neutral at UBS
Forest Laboratories Inc. (NYSE: FRX) was upgraded to Buy from Neutral at Goldman Sachs.
Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) has run into an FDA delay of its hepatitis C drug trial and shares are down by more than a third. Analysts have downgraded in mass: to Underperform at Baird, to Hold at Deutsche Bank, to Underperform at JMP Securities and to Neutral at J.P. Morgan.
Kimberly-Clark Corp. (NYSE: KMB) was upgraded to Market Perform from Underperform at BMO Capital Markets. We also just named this as one of four key stocks that investors will flock back into after the market flush ends.
Newmont Mining Corp. (NYSE: NEM) was downgraded to Neutral from Buy at UBS, after being downgraded by Cowen & Co. yesterday.
Read also: UBS Updated Its Key Call List of Stocks
The Wendy’s Co. (NASDAQ: WEN) was started as Market Perform at Wells Fargo.